Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications

被引：10

作者：

Bucur, O. ^{[2
,3
,4
]}

Stancu, A. L. ^{[2
,3
,5
]}

Khosravi-Far, R. ^{[2
,3
]}

Almasan, A. ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA

[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA

[3] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

[4] Romanian Acad, Inst Biochem, Dept Mol & Cell Biol, Bucharest, Romania

[5] Carol Davila Univ Med & Pharm, Bucharest, Romania

来源：

CELL DEATH & DISEASE | 2012年 / 3卷

关键词：

MITOCHONDRIAL PERMEABILITY TRANSITION; EPITHELIAL-MESENCHYMAL TRANSITION; METASTASIS-ASSOCIATED PROTEIN-1; ACUTE LYMPHOBLASTIC-LEUKEMIA; SIGNAL-REGULATED KINASE; ESTROGEN-RECEPTOR-ALPHA; RENAL-CARCINOMA CELLS; PRIMARY BREAST-CANCER; HUMAN-MELANOMA CELLS; TUMOR-CELLS;

D O I：

10.1038/cddis.2012.2

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

[No abstract available]

引用

页码：e263 / e263

页数：5

共 317 条

[1] Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1 [J].

Ahmed, A. ;

Yang, J. ;

Maya-Mendoza, A. ;

Jackson, D. A. ;

Ashcroft, M. .

CELL DEATH & DISEASE, 2011, 2 :e160-e160

[2] Ocular neuroprotection by siRNA targeting caspase-2 [J].

Ahmed, Z. ;

Kalinski, H. ;

Berry, M. ;

Almasieh, M. ;

Ashush, H. ;

Slager, N. ;

Brafman, A. ;

Spivak, I. ;

Prasad, N. ;

Mett, I. ;

Shalom, E. ;

Alpert, E. ;

Di Polo, A. ;

Feinstein, E. ;

Logan, A. .

CELL DEATH & DISEASE, 2011, 2 :e173-e173

[3] Generation and characterization of antibodies specific for caspase-cleaved neo-epitopes: a novel approach [J].

Ai, X. ;

Butts, B. ;

Vora, K. ;

Li, W. ;

Tache-Talmadge, C. ;

Fridman, A. ;

Mehmet, H. .

CELL DEATH & DISEASE, 2011, 2 :e205-e205

[4] Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98 [J].

Alajez, N. M. ;

Shi, W. ;

Hui, A. B. Y. ;

Bruce, J. ;

Lenarduzzi, M. ;

Ito, E. ;

Yue, S. ;

O'Sullivan, B. ;

Liu, F-F .

CELL DEATH & DISEASE, 2010, 1 :e85-e85

[5] CYLD regulates keratinocyte differentiation and skin cancer progression in humans [J].

Alameda, J. P. ;

Fernandez-Acenero, M. J. ;

Moreno-Maldonado, R. ;

Navarro, M. ;

Quintana, R. ;

Page, A. ;

Ramirez, A. ;

Bravo, A. ;

Casanova, M. L. .

CELL DEATH & DISEASE, 2011, 2 :e208-e208

[6] Immunologic Consequences of Signal Transducers and Activators of Transcription 3 Activation in Human Squamous Cell Carcinoma [J].

Albesiano, Emilia ;

Davis, Meghan ;

See, Alfred P. ;

Han, James E. ;

Lim, Michael ;

Pardoll, Drew M. ;

Kim, Young .

CANCER RESEARCH, 2010, 70 (16) :6467-6476

[7] Type 1 Insulin-like Growth Factor Receptor Translocates to the Nucleus of Human Tumor Cells [J].

Aleksic, Tamara ;

Chitnis, Meenali M. ;

Perestenko, Olga V. ;

Gao, Shan ;

Thomas, Peter H. ;

Turner, Gareth D. ;

Protheroe, Andrew S. ;

Howarth, Mark ;

Macaulay, Valentine M. .

CANCER RESEARCH, 2010, 70 (16) :6412-6419

[8] Loss of protein kinase C delta alters mammary gland development and apoptosis [J].

Allen-Petersen, B. L. ;

Miller, M. R. ;

Neville, M. C. ;

Anderson, S. M. ;

Nakayama, K. I. ;

Reyland, M. E. .

CELL DEATH & DISEASE, 2010, 1 :e17-e17

[9] Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors [J].

Almasieh, M. ;

Zhou, Y. ;

Kelly, M. E. ;

Casanova, C. ;

Di Polo, A. .

CELL DEATH & DISEASE, 2010, 1 :e27-e27

[10] CCT241533 Is a Potent and Selective Inhibitor of CHK2 that Potentiates the Cytotoxicity of PARP Inhibitors [J].

Anderson, Victoria E. ;

Walton, Michael I. ;

Eve, Paul D. ;

Boxall, Katherine J. ;

Antoni, Laurent ;

Caldwell, John J. ;

Aherne, Wynne ;

Pearl, Laurence H. ;

Oliver, Antony W. ;

Collins, Ian ;

Garrett, Michelle D. .

CANCER RESEARCH, 2011, 71 (02) :463-472

← 1 2 3 4 5 6 7 8 9 10 →